Tranilast is a synthetic antioxidant agent and cinnamamide derivative primarily utilized in the treatment of conditions such as bronchial asthma, keloid scars, and oligozoospermia by inhibiting tyrosine… Read more
Tranilast is a synthetic antioxidant agent and cinnamamide derivative primarily utilized in the treatment of conditions such as bronchial asthma, keloid scars, and oligozoospermia by inhibiting tyrosine kinase activity. This category provides essential reference standards for the active pharmaceutical ingredient, including its sodium salt and various stereoisomers, such as cis- and trans-Tranilast, which are critical for accurate purity assessment. Pharmaceutical laboratories rely on this collection for comprehensive impurity profiling and method validation during drug development. The inclusion of stable isotope labelled compounds, such as 13C3 and deuterated d6 analogues, facilitates precise quantification in mass spectrometry-based analytical testing. By offering these high-quality materials, this selection supports rigorous quality control protocols and the investigation of degradation products or metabolic pathways related to this therapeutic agent.